At KorNutra, we get a certain kind of phone call pretty often. A brand wants a sulforaphane gummy. They’ve got a dose in mind, a flavor picked out, and a launch timeline ready. Then we ask the question that usually brings everything to a pause: How are you planning to keep the enzyme alive inside a warm, wet, acidic piece of candy?
That’s when the project gets real. The difficulty sits in the chemistry. Sulforaphane is a reaction product, and a gummy is close to the worst environment you could pick to run a controlled chemical reaction.
You’re Not Starting with Sulforaphane
Sulforaphane is a sulfur-containing isothiocyanate. In nature, it doesn’t sit around in broccoli waiting to be bottled. The raw material you actually buy is typically glucoraphanin, a glucosinolate precursor, paired with an enzyme called myrosinase.
When glucoraphanin and myrosinase meet in the presence of water, the enzyme cleaves off a glucose group and the resulting molecule rearranges into sulforaphane. That sounds simple until you account for two things. The product forms only after a water-dependent reaction, and once it forms, it degrades. A neat sulforaphane sample lost about 75% of its content in 6 days at 37°C, and sulforaphane is far less stable in aqueous systems than in dry, non-aqueous ones.
A formulator has to manage an enzyme, a precursor, a reaction intermediate, and several degradation pathways at the same time, all inside a confection that is by definition wet.
Heat, Water Activity, and pH in the Gummy Matrix
From a formulator’s perspective, a traditional gummy is hostile territory for sulforaphane chemistry:
- Water activity in the 0.55-0.66 range. That’s plenty of free water to support slow enzymatic conversion and hydrolytic degradation over shelf life.
- Slurry temperatures of 160-190°F during cooking. Myrosinase begins losing activity around 95°F and is largely inactivated by 140°F. Sulfur compounds don’t love that kind of heat either.
- Acidic pH in the 3.0-4.0 range. Acidic conditions can push the reaction toward nitriles and other breakdown products instead of sulforaphane.
- A matrix full of reactive components. Corn syrup, sucrose, pectin or gelatin, and citric acid all carry reactive groups that can accelerate degradation.
A delicate reaction system sits in a warm, wet, acidic environment that keeps working against it for the next 18 to 24 months.
The Dead Enzyme Problem
One of the most common failures we see at KorNutra during technical review is what we call the dead enzyme problem.
A formula lists glucoraphanin and myrosinase. On paper, the concept looks fine. In production, the gummy slurry is cooked at high temperature, then cooled slightly for flavor and acid addition. If the myrosinase is added too early, while the mass is still hot, the enzyme denatures. The finished gummy may contain glucoraphanin, but it contains no active myrosinase.
That means the intended conversion cannot happen. You end up with a precursor-only formula labeled and marketed around sulforaphane, while the enzyme needed to make it is functionally gone.
At KorNutra, we don’t accept ingredient presence as proof of performance. We assay for myrosinase activity in the finished gummy, not just glucoraphanin content. A gummy with inactive enzyme is a failed chemistry experiment with good flavoring.
How We Approach Sulforaphane Gummy Formulation
There’s no single trick that solves this. It requires layered formulation strategies.
Thermal Separation
We never add heat-sensitive actives to a hot slurry. The base is cooked and cooled below the enzyme degradation threshold before the functional suspension is added. That often means working in a high-viscosity, low-temperature window where the gummy mass is still pourable but not actively denaturing the enzyme.
Encapsulation for Separation
Mixing glucoraphanin and myrosinase into a wet gummy base invites premature reaction during manufacturing and storage. We use encapsulation to physically separate the enzyme from the precursor in the wet matrix. The shell must remain intact in the gummy’s water phase and under acidic pH, while still releasing under intended use conditions. Release is usually designed for the mouth or for a near-neutral aqueous environment, because gastric acid can reduce myrosinase activity on its own. Many encapsulation systems work in dry powders but fail in high-moisture confections because the shell dissolves or becomes permeable over time.
Low-Water Formats and pH Control
Traditional gummy water activity is too high for long-term sulforaphane stability. We evaluate lower-moisture gummy bases, humectant adjustments, and buffering strategies. A pH-neutral gummy would create its own microbial and flavor problems, so the aim is to reduce the most aggressive degradation drivers without losing the gummy’s structure.
Enzyme-Added-Last Processing
For some prototypes, the enzyme is not added to the bulk slurry at all. It is introduced as a separately prepared suspension at the coolest viable point in the process. This requires careful mixing to avoid clumping, but it can improve enzyme activity retention.
How We Test Sulforaphane Gummies
You cannot manage what you do not measure. For sulforaphane gummies, the analytical burden is much higher than for a standard vitamin gummy.
At KorNutra, we run cold extraction methods that prevent continued enzymatic conversion during sample preparation. We use HPLC or UPLC assays for glucoraphanin, sulforaphane, and degradation markers. We measure enzyme activity in the finished gummy as well as in the raw material. We run accelerated stability at elevated temperature and humidity to see how the reaction system behaves over time. We also test homogeneity across the batch, because high-sugar matrices can cause uneven distribution of functional components.
The most important rule is to never label theoretical sulforaphane. Adding 20 mg of glucoraphanin does not yield 20 mg of sulforaphane. Conversion efficiency, enzyme activity, and degradation all cut into the actual amount present. In one model system, hydrolyzing a glucoraphanin standard with extracted myrosinase converted about 48% of it to sulforaphane before the reaction equilibrated. A real specification is based on measured sulforaphane in the finished product at the end of shelf life, not on a spreadsheet calculation.
The Regulatory and Labeling Reality
Under 21 CFR 111.70, every dietary supplement manufacturer must establish specifications for identity, purity, strength, and composition of the finished batch. For sulforaphane gummies, the finished product specification is where many projects get into trouble.
If the product is labeled as containing sulforaphane, you need validated analytical data showing that the finished gummy contains the labeled amount through the expiration date. If the product contains glucoraphanin and myrosinase but no measurable sulforaphane at time zero, then the label should reflect what is actually present: the precursor and the enzyme.
At KorNutra, we recommend labeling the measured marker compound, not the theoretical end product. Labeling the measured marker is a quality commitment as much as a legal one. A well-made product should be able to prove its content with data. We also stay firmly away from medical or health claims. Sulforaphane gummies should be positioned and labeled based on their actual composition, not on therapeutic promises.
Sulfur Off-Notes and Flavor Masking
Sulforaphane and its related compounds are sulfurous. In a gummy, heat, acid, and fruit flavors can push the system toward off-notes that range from cooked cabbage to a bitter metallic aftertaste.
Masking takes encapsulation, cooling during flavor addition, and often several masking technologies at once. The goal is a gummy that tastes like a gummy, with no hint of broccoli water.
The Gut Conversion Fallback
Some formulators argue that a precursor-only gummy still delivers sulforaphane because gut bacteria can hydrolyze glucoraphanin after the plant enzyme is gone. That conversion is real. Intestinal microbiota convert glucoraphanin to sulforaphane, which is one reason cooked broccoli still yields some sulforaphane. But the yield varies with the individual’s microbiome and is difficult to predict or control. A product that leans on gut conversion is betting on the consumer’s bacteria rather than on measured content. If the label names sulforaphane, the finished-product data still has to show it. We treat active enzyme as the primary mechanism and gut conversion as a fallback, not a specification.
The KorNutra Takeaway
Sulforaphane gummies are possible, but they are one of the most technically demanding challenges in the nutraceutical gummy category. The brands that succeed are the ones that understand they are building an enzyme reaction system inside a water-based confection.
If someone quotes a sulforaphane gummy like a standard vitamin C gummy, that’s a red flag. The process needs tighter temperature control, more analytical work, and a different approach to stability. At KorNutra, that’s the kind of challenge we plan for from day one, because a gummy that loses its chemistry before the end of shelf life should not ship.